Depression Clinical Trials in Austin, Texas

7 studies are recruiting for depression in Austin, Texas right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder

   The purpose of this study is to determine the efficacy, safety and tolerability of CYB003 compared to matching placebo as adjunctive treatment in patients with MDD. For more information about the EMBRACE study, including participating study locations, and to register your interest in learning more …

   Stage

   Phase 3

   Ages

   18 to 85

   Site

   Austin Clinical Trial Partners, Austin, Texas

   Locations

   69 in total

   Run by

   Cybin IRL Limited

   See if you can join NCT06793397 on ClinicalTrials.gov

2. Accelerated Intermittent Theta Burst in Treatment-Naive Adolescents

   This is a single-site open-label clinical trial of fMRI-guided accelerated intermittent theta burst stimulation. The goal of this clinical trial is to learn if a new form of transcranial magnetic stimulation (TMS)-known generally as accelerated intermittent theta burst stimulation (aiTBS)-is effect…

   Stage

   Not phased

   Ages

   13 to 20

   Site

   Dell Medical School at University of Texas at Austin, Austin, Texas

   Run by

   University of Texas at Austin

   See if you can join NCT06523439 on ClinicalTrials.gov

3. A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.

   Bipolar disorder is a severe chronic mood disorder that affects up to 4% of the adult population and 1.8% of the pediatric population in the United States. The treatment of the depressive episodes of bipolar disorder in the pediatric population has not been as widely studied as the treatment of dep…

   Stage

   Phase 3

   Ages

   10 to 17

   Site

   BioBehavioral Research of Austin /ID# 227076, Austin, Texas

   Locations

   81 in total

   Run by

   AbbVie

   See if you can join NCT04777357 on ClinicalTrials.gov

4. A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)

   The goal of this clinical trial is to learn if a drug called TNX-102 SL works to treat moderate to severe major depressive disorder in adults. It will also learn about the safety of TNX-102 SL. The main questions it aims to answer are: Does TNX-102 SL improve depression symptoms according to a depr…

   Stage

   Phase 2

   Ages

   18 and older

   Site

   Austin Clinical Trial Partners, Austin, Texas

   Locations

   25 in total

   Run by

   Tonix Pharmaceuticals, Inc.

   See if you can join NCT07621237 on ClinicalTrials.gov

5. Psilocybin rTMS for Treatment Resistant Depression

   The purpose of this study is to determine the safety and feasibility of sequencing psilocybin therapy with a short-duration, aiTBS protocol (Stanford Accelerated Intelligent Neuromodulation Therapy, or SAINT) in individuals with treatment-resistant major depressive disorder.

   Stage

   Phase 2

   Ages

   22 to 65

   Site

   Health Discovery Building (HDB), 1601 Trinity St., Bldg B., Z0600, Austin, Texas

   Run by

   University of Texas at Austin

   See if you can join NCT06132178 on ClinicalTrials.gov

6. Confirmatory Efficacy Trial of Attention Bias Modification for Depression

   The goal of this clinical trial is to compare the efficacy of two related, but different ABM (Attention Biased Modification) treatments for depression in adults with elevated symptoms of depression. The main aims are: * Aim 1:examine whether gamified ABM leads to greater change in the primary and s…

   Stage

   EARLY_Phase 1

   Ages

   18 to 70

   Site

   Institute for Mental Health Research, Austin, Texas

   Run by

   University of Texas at Austin

   See if you can join NCT06361095 on ClinicalTrials.gov

7. To Improve Depressive Symptoms Using a Web-App

   This study is being done to answer a question on whether a Web App-based Lifestyle Physical Activity Promotion Program is effective in improving depressive symptom experience of midlife Korean American women (WPAPP-K).

   Stage

   Not phased

   Ages

   40 to 60

   Site

   The University of Texas at Austin, Austin, Texas

   Run by

   University of Texas at Austin

   See if you can join NCT05405803 on ClinicalTrials.gov